Metabolic benefits of 17α-estradiol in liver are partially mediated by ERβ in male mice
Open Access
- 17 June 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-14
Abstract
Metabolic dysfunction underlies several chronic diseases. Dietary interventions can reverse metabolic declines and slow aging but remaining compliant is difficult. 17α-estradiol (17α-E2) treatment improves metabolic parameters and slows aging in male mice without inducing significant feminization. We recently reported that estrogen receptor α is required for the majority of 17α-E2-mediated benefits in male mice, but that 17α-E2 also attenuates fibrogenesis in liver, which is regulated by estrogen receptor β (ERβ)-expressing hepatic stellate cells (HSC). The current studies sought to determine if 17α-E2-mediated benefits on systemic and hepatic metabolism are ERβ-dependent. We found that 17α-E2 treatment reversed obesity and related systemic metabolic sequela in both male and female mice, but this was partially blocked in female, but not male, ERβKO mice. ERβ ablation in male mice attenuated 17α-E2-mediated benefits on hepatic stearoyl-coenyzme A desaturase 1 (SCD1) and transforming growth factor β1 (TGF-β1) production, which play critical roles in HSC activation and liver fibrosis. We also found that 17α-E2 treatment suppresses SCD1 production in cultured hepatocytes and hepatic stellate cells, indicating that 17α-E2 directly signals in both cell-types to suppress drivers of steatosis and fibrosis. We conclude that ERβ partially controls 17α-E2-mediated benefits on systemic metabolic regulation in female, but not male, mice, and that 17α-E2 likely signals through ERβ in HSCs to attenuate pro-fibrotic mechanisms.Keywords
Funding Information
- National Institute on Aging (T32 AG052363, R00 AG056662, R00 AG051661)
- U.S. Department of Veterans Affairs (I01 BX005592, Pilot Research Funding)
This publication has 80 references indexed in Scilit:
- The Hallmarks of AgingCell, 2013
- Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human conditionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Fat tissue, aging, and cellular senescenceAging Cell, 2010
- Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in miceDisease Models & Mechanisms, 2010
- Obesity accelerates thymic agingBlood, 2009
- Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Metabolic Actions of Estrogen Receptor Beta (ERβ) are Mediated by a Negative Cross-Talk with PPARγPLOS Genetics, 2008
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Hepatic Stellate Cells Contain the Functional Estrogen Receptor β but Not the Estrogen Receptor α in Male and Female RatsBiochemical and Biophysical Research Communications, 2001